Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS

被引:0
|
作者
Andrea Giaccari
R. C. Bonadonna
R. Buzzetti
G. Perseghin
D. Cucinotta
C. Fanelli
A. Avogaro
G. Aimaretti
M. Larosa
V. Pagano
G. B. Bolli
机构
[1] Fondazione Policlinico Universitario A. Gemelli IRCCS,Division of Endocrinology and Metabolic Diseases and Department of Medicine and Surgery
[2] Rome and Università Cattolica del Sacro Cuore,Section of Endocrinology and Metabolism, Department of Medicine
[3] University of Parma and AOU of Parma,undefined
[4] Sapienza University of Rome,undefined
[5] University of Milan Bicocca,undefined
[6] University of Messina,undefined
[7] Perugia University Medical School,undefined
[8] University of Padua,undefined
[9] University of the Eastern Piedmont,undefined
[10] Sanofi,undefined
[11] OPIS s.r.l.,undefined
[12] Palazzo Aliprandi,undefined
来源
Acta Diabetologica | 2021年 / 58卷
关键词
Insulin glargine 300 U/mL; Titration; Self-titration; Hypoglycaemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:789 / 796
页数:7
相关论文
共 35 条
  • [1] Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS
    Giaccari, Andrea
    Bonadonna, R. C.
    Buzzetti, R.
    Perseghin, G.
    Cucinotta, D.
    Fanelli, C.
    Avogaro, A.
    Aimaretti, G.
    Larosa, M.
    Pagano, V
    Bolli, G. B.
    [J]. ACTA DIABETOLOGICA, 2021, 58 (06) : 789 - 796
  • [2] Comparison of patient vs physician-managed algorithm for titrating insulin glargine 300 U/ml in type 2 diabetes: the ITAS study
    Giaccari, A.
    Bonadonna, R. C.
    Buzzetti, R.
    Perseghin, G.
    Cucinotta, D.
    Avogaro, A.
    Aimaretti, G.
    Larosa, M.
    Fanelli, C.
    Bolli, G.
    [J]. DIABETOLOGIA, 2019, 62 : S437 - S437
  • [3] TAKE CONTROL: EFFICACY AND SAFETY OF PATIENT-VERSUS PHYSICIAN-MANAGED TITRATION OF INSULIN GLARGINE 300 U/ML (GLA-300) IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES
    Russell-Jones, D.
    Dauchy, A.
    Delgado, E.
    Dimitriadis, G.
    Frandsen, H. A.
    Popescu, L.
    Schultes, B.
    Strojek, K.
    Bonnemaire, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A33 - A34
  • [4] TAKE CONTROL: Efficacy and safety of patient-versus physician-managed titration of insulin Glargine 300 U/Ml (Gla-300) in patients with uncontrolled type 2 diabetes
    Russel-Jones, David
    Dauchy, Arnaud
    Delgado, Elias
    Dimitriadis, George
    Frandsen, Hans Albert
    Popescu, Luiza
    Schultes, Bernd
    Strojek, Krzysztof
    Harreiter, Juergen
    Bonnemaire, Mireille
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 365 - 365
  • [5] Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes
    Russell-Jones, David
    Dauchy, Arnaud
    Delgado, Elias
    Dimitriadis, George
    Frandsen, Hans A.
    Popescu, Luiza
    Schultes, Bernd
    Strojek, Krzysztof
    Bonnemaire, Mireille
    de Climens, Aude Roborel
    Davies, Melanie
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1615 - 1624
  • [6] Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes
    Yale, J-F
    Aroda, V. R.
    Charbonnel, B.
    Sinclair, A. J.
    Trescoli, C.
    Cahn, A.
    Bigot, G.
    Merino-Trigo, A.
    Brulle-Wohlhueter, C.
    Bolli, G. B.
    Ritzel, R.
    [J]. DIABETES & METABOLISM, 2020, 46 (02) : 110 - 118
  • [7] Self-managed titration with insulin Glargine 300 U/mL can achieve similar efficacy to physician-led titration regardless of prior insulin status in T2 DM-Results from TAKE CONTROL
    Delgado, Elias
    Harreiter, Juergen
    Bonnemaire, Mireille
    Dauchy, Arnaud
    Donicova, Viera
    Kvapil, Milan
    Tentolouris, Nikolaos
    Popescu, Luiza
    Russel-Jones, David
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 366 - 367
  • [8] Self-Managed Titration with Insulin Glargine 300 U/mL (Gla-300) Can Achieve Similar Efficacy to Physician-Led Titration Regardless of Prior Insulin Status in People with T2DM-Results from TAKE CONTROL
    Delgado, Elias
    Bonnemaire, Mireille
    Dauchy, Arnaud
    Donicova, Viera
    Kvapil, Milan
    Tentolouris, Nikolaos
    Popescu, Luiza
    Russell-Jones, David
    [J]. DIABETES, 2018, 67
  • [9] Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
    Ritzel, R.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Brulle-Wohlhueter, C.
    Glezer, S.
    Yki-Jaervinen, H.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 859 - 867
  • [10] NEW INSULIN GLARGINE 300 U/ML: GLYCEMIC CONTROL AND HYPOGLYCEMIA IN A META-ANALYSIS OF EDITION CLINICAL TRIALS IN PEOPLE WITH T2DM
    Ritzel, R. A.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Yki-Jarvinen, H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A16 - A17